Shao Siong Chua 蔡少雄

Shao Siong Chua 蔡少雄 has worked in the pharmaceutical industry since 2000. In 2000, they started as a Process Engineer at DuPont. In 2002, they joined GSK as a Value Stream Mfg Lead, R&D Operations Lead, OE Expert, and Production Engineer, where they were responsible for commissioning of new facility and processes. In 2010, they became the Head of Manufacturing at Baxter International Inc. In 2015, they moved to Baxalta as the Head of Manufacturing. In 2016, they joined Novartis as the Head Manufacturing Unit (BioProduction Ops) and Site Head (ad-interim), where they were responsible for overall Singapore biologics manufacturing operations and represented Singapore Site in the Novartis Large Molecules platform. In 2021, they became the GM, Manufacturing Operations, Singapore at RVAC Medicines.

Shao Siong Chua 蔡少雄 earned a Master of Engineering (MEng) with Business in Chemical and Biomolecular Engineering from the National University of Singapore between 1995 and 2000.